Header Logo

Connection

Joyce Fingeroth to Receptors, Complement 3d

This is a "connection" page, showing publications Joyce Fingeroth has written about Receptors, Complement 3d.
Connection Strength

1.646
  1. Arredouani MS, Bhasin MK, Sage DR, Dunn LK, Gill MB, Agnani D, Libermann TA, Fingeroth JD. Analysis of host gene expression changes reveals distinct roles for the cytoplasmic domain of the Epstein-Barr virus receptor/CD21 in B-cell maturation, activation, and initiation of virus infection. J Virol. 2014 May; 88(10):5559-77.
    View in: PubMed
    Score: 0.447
  2. Ogembo JG, Kannan L, Ghiran I, Nicholson-Weller A, Finberg RW, Tsokos GC, Fingeroth JD. Human complement receptor type 1/CD35 is an Epstein-Barr Virus receptor. Cell Rep. 2013 Feb 21; 3(2):371-85.
    View in: PubMed
    Score: 0.415
  3. Gill MB, Roecklein-Canfield J, Sage DR, Zambela-Soediono M, Longtine N, Uknis M, Fingeroth JD. EBV attachment stimulates FHOS/FHOD1 redistribution and co-aggregation with CD21: formin interactions with the cytoplasmic domain of human CD21. J Cell Sci. 2004 Jun 01; 117(Pt 13):2709-20.
    View in: PubMed
    Score: 0.226
  4. Prota AE, Sage DR, Stehle T, Fingeroth JD. The crystal structure of human CD21: Implications for Epstein-Barr virus and C3d binding. Proc Natl Acad Sci U S A. 2002 Aug 06; 99(16):10641-6.
    View in: PubMed
    Score: 0.199
  5. Fingeroth JD, Diamond ME, Sage DR, Hayman J, Yates JL. CD21-Dependent infection of an epithelial cell line, 293, by Epstein-Barr virus. J Virol. 1999 Mar; 73(3):2115-25.
    View in: PubMed
    Score: 0.158
  6. Bowles SL, Jaeger C, Ferrara C, Fingeroth J, Van De Venter M, Oosthuizen V. Comparative binding of soluble fragments (derCD23, sCD23, and exCD23) of recombinant human CD23 to CD21 (SCR 1-2) and native IgE, and their effect on IgE regulation. Cell Immunol. 2011; 271(2):371-8.
    View in: PubMed
    Score: 0.093
  7. Hu H, Luo ML, Desmedt C, Nabavi S, Yadegarynia S, Hong A, Konstantinopoulos PA, Gabrielson E, Hines-Boykin R, Pihan G, Yuan X, Sotiriou C, Dittmer DP, Fingeroth JD, Wulf GM. Epstein-Barr Virus Infection of Mammary Epithelial Cells Promotes Malignant Transformation. EBioMedicine. 2016 Jul; 9:148-160.
    View in: PubMed
    Score: 0.033
  8. Fingeroth JD. Comparative structure and evolution of murine CR2. The homolog of the human C3d/EBV receptor (CD21). J Immunol. 1990 May 01; 144(9):3458-67.
    View in: PubMed
    Score: 0.021
  9. Fingeroth JD, Heath ME, Ambrosino DM. Proliferation of resting B cells is modulated by CR2 and CR1. Immunol Lett. 1989 Jun 15; 21(4):291-301.
    View in: PubMed
    Score: 0.020
  10. Fingeroth JD, Clabby ML, Strominger JD. Characterization of a T-lymphocyte Epstein-Barr virus/C3d receptor (CD21). J Virol. 1988 Apr; 62(4):1442-7.
    View in: PubMed
    Score: 0.019
  11. Fingeroth JD, Weis JJ, Tedder TF, Strominger JL, Biro PA, Fearon DT. Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2. Proc Natl Acad Sci U S A. 1984 Jul; 81(14):4510-4.
    View in: PubMed
    Score: 0.014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.